Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The study population will be 80 adult men who have been diagnosed with prostate cancer who
are scheduled to have their prostate surgically removed at either the Medical University of
South Carolina (MUSC) or the Ralph H. Johnson VAMC, both located in Charleston, SC. The men
will be randomized into two groups: one group will take vitamin D3 supplementation and the
other will take a placebo. Blood levels of vitamin D3 will be obtained at the beginning of
the study and again after two months, just prior to the surgical procedure (prostatectomy).
Prostate tissue will be obtained from the surgical procedure and studied for the effect of
vitamin D on the prostate cancer cells.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins